Published in Invest Ophthalmol Vis Sci on December 01, 2004
Designing a new test for contrast sensitivity function measurement with iPad. J Optom (2014) 0.99
Assessment of contrast gain signature in inferred magnocellular and parvocellular pathways in patients with glaucoma. Vision Res (2008) 0.96
Contrast response properties of magnocellular and parvocellular pathways in retinitis pigmentosa assessed by the visual evoked potential. Invest Ophthalmol Vis Sci (2005) 0.82
Equivalent intrinsic noise, sampling efficiency, and contrast sensitivity in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (2013) 0.79
Contrast visual acuity in patients with retinitis pigmentosa assessed by a contrast sensitivity tester. Indian J Ophthalmol (2012) 0.75
Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis. Graefes Arch Clin Exp Ophthalmol (2014) 0.75
Multidimensional Functional and Structural Evaluation Reveals Neuroretinal Impairment in Early Diabetic Retinopathy. Invest Ophthalmol Vis Sci (2017) 0.75
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A (2008) 7.16
Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature (2005) 5.96
Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol (2011) 3.79
Human and macaque pupil responses driven by melanopsin-containing retinal ganglion cells. Vision Res (2007) 2.64
Night blindness and abnormal cone electroretinogram ON responses in patients with mutations in the GRM6 gene encoding mGluR6. Proc Natl Acad Sci U S A (2005) 2.36
A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. Am J Hum Genet (2002) 2.29
Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol (2006) 2.27
Retinal phenotypes in patients homozygous for the G1961E mutation in the ABCA4 gene. Invest Ophthalmol Vis Sci (2012) 2.26
Detection of mosaic retinal dysfunction in choroideremia carriers electroretinographic and psychophysical testing. Ophthalmology (2008) 2.14
Association of dark-adapted visual function with retinal structural changes in patients with Stargardt disease. Retina (2014) 1.99
Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration. Nat Genet (2012) 1.96
Analysis of the ABCA4 gene by next-generation sequencing. Invest Ophthalmol Vis Sci (2011) 1.87
Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Arch Ophthalmol (2010) 1.85
Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology (2003) 1.69
Photoreceptor structure and function in patients with congenital achromatopsia. Invest Ophthalmol Vis Sci (2011) 1.61
iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet (2012) 1.59
How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa? Arch Ophthalmol (2010) 1.56
Identification of novel mutations in patients with Leber congenital amaurosis and juvenile RP by genome-wide homozygosity mapping with SNP microarrays. Invest Ophthalmol Vis Sci (2007) 1.54
Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease. Invest Ophthalmol Vis Sci (2012) 1.47
Comprehensive molecular diagnosis of 179 Leber congenital amaurosis and juvenile retinitis pigmentosa patients by targeted next generation sequencing. J Med Genet (2013) 1.47
Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Arch Ophthalmol (2010) 1.46
The prevalence of macular cysts in patients with clinical cone-rod dystrophy determined by spectral-domain optical coherence tomography. Ophthalmic Genet (2013) 1.45
Immunosuppression for autoimmune retinopathy. Arch Ophthalmol (2009) 1.43
Correlation of optical coherence tomography findings with visual acuity and macular lesions in patients with X-linked retinoschisis. Ophthalmology (2005) 1.43
Retinal nerve fiber layer analysis in RP patients using Fourier-domain OCT. Invest Ophthalmol Vis Sci (2008) 1.37
Retinal nerve fiber layer defects in RP patients. Invest Ophthalmol Vis Sci (2007) 1.36
Visual acuity in patients with Leber's congenital amaurosis and early childhood-onset retinitis pigmentosa. Ophthalmology (2010) 1.30
BBS genotype-phenotype assessment of a multiethnic patient cohort calls for a revision of the disease definition. Hum Mutat (2011) 1.28
Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease. Hum Mol Genet (2013) 1.27
Visual stimulus-induced changes in human near-infrared fundus reflectance. Invest Ophthalmol Vis Sci (2006) 1.26
Differential macular morphology in patients with RPE65-, CEP290-, GUCY2D-, and AIPL1-related Leber congenital amaurosis. Invest Ophthalmol Vis Sci (2009) 1.24
Autosomal recessive vitelliform macular dystrophy in a large cohort of vitelliform macular dystrophy patients. Retina (2011) 1.24
CERKL mutations cause an autosomal recessive cone-rod dystrophy with inner retinopathy. Invest Ophthalmol Vis Sci (2009) 1.21
Evaluation of genotype-phenotype associations in leber congenital amaurosis. Retina (2005) 1.14
Use of dorzolamide for patients with X-linked retinoschisis. Retina (2006) 1.14
Monitoring cystoid macular edema by optical coherence tomography in patients with retinitis pigmentosa. Ophthalmology (2004) 1.10
Natural history of phenotypic changes in Stargardt macular dystrophy. Ophthalmic Genet (2009) 1.10
Variability of full-field electroretinogram responses in subjects without diffuse photoreceptor cell disease. Ophthalmology (2003) 1.10
Improvement in visual function and fundus findings for a patient with vitamin A-deficient retinopathy. Retina (2005) 1.09
Retinal thickness and visual thresholds measured in patients with retinitis pigmentosa. Retina (2007) 1.09
Matching rod percepts with cone stimuli. Vision Res (2005) 1.09
Detection using the multifocal electroretinogram of mosaic retinal dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology (2002) 1.09
Linking impulse response functions to reaction time: rod and cone reaction time data and a computational model. Vision Res (2007) 1.07
Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa. Retina (2007) 1.06
Discordant phenotypes in fraternal twins having an identical mutation in exon ORF15 of the RPGR gene. Arch Ophthalmol (2008) 1.06
Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin. Am J Ophthalmol (2008) 1.06
The natural history of stargardt disease with specific sequence mutation in the ABCA4 gene. Invest Ophthalmol Vis Sci (2009) 1.06
ON-pathway dysfunction and timing properties of the flicker ERG in carriers of X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci (2003) 1.05
Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia. Retina (2012) 1.05
Autoimmune retinopathy and antiretinal antibodies: a review. Retina (2014) 1.04
Variations in NPHP5 in patients with nonsyndromic leber congenital amaurosis and Senior-Loken syndrome. Arch Ophthalmol (2011) 1.04
Eye-movement training for reading in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci (2005) 1.03
Macular vitelliform lesion in desferrioxamine-related retinopathy. Doc Ophthalmol (2010) 1.02
Mutations in chaperonin-like BBS genes are a major contributor to disease development in a multiethnic Bardet-Biedl syndrome patient population. J Med Genet (2010) 1.02
Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells. J Neurosci (2011) 1.02
Infrared scanning laser ophthalmoscope imaging of the macula and its correlation with functional loss and structural changes in patients with stargardt disease. Retina (2011) 1.01
Rod contributions to color perception: linear with rod contrast. Vision Res (2008) 1.01
Assessing retinal structure in complete congenital stationary night blindness and Oguchi disease. Am J Ophthalmol (2012) 1.00
The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis. Retina (2011) 1.00
Peripapillary retinal nerve fiber layer thinning in patients with autosomal recessive cone-rod dystrophy. Am J Ophthalmol (2009) 0.98
Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23. Am J Ophthalmol (2003) 0.98
Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration. Ophthalmology (2013) 0.97
Dark-adapted rod suppression of cone flicker detection: Evaluation of receptoral and postreceptoral interactions. Vis Neurosci (2006) 0.97
Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome. Doc Ophthalmol (2010) 0.96
CRB1 gene mutations are associated with keratoconus in patients with leber congenital amaurosis. Invest Ophthalmol Vis Sci (2009) 0.96
A distinctive form of congenital stationary night blindness with cone ON-pathway dysfunction. Ophthalmology (2002) 0.96
A substitution of G to C in the cone cGMP-phosphodiesterase gamma subunit gene found in a distinctive form of cone dystrophy. Ophthalmology (2005) 0.96
Mutated alleles of the rod and cone Na-Ca+K-exchanger genes in patients with retinal diseases. Invest Ophthalmol Vis Sci (2002) 0.95
Audiophile hardware in vision science; the soundcard as a digital to analog converter. J Neurosci Methods (2005) 0.95
Intersession repeatability of humphrey perimetry measurements in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (2007) 0.95
Dynamics of sensitivity regulation in primate outer retina: the horizontal cell network. J Vis (2003) 0.95
Microperimetry and OCT findings in female carriers of choroideremia. Ophthalmic Genet (2010) 0.95
Retinal dysfunction in carriers of bardet-biedl syndrome. Ophthalmic Genet (2007) 0.94
Spatial frequency processing in inferred PC- and MC-pathways. Vision Res (2003) 0.94
Contrast-processing deficits in melanoma-associated retinopathy. Invest Ophthalmol Vis Sci (2004) 0.93
Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy. Invest Ophthalmol Vis Sci (2002) 0.93
Treatment of cystic macular lesions in hereditary retinal dystrophies. Surv Ophthalmol (2013) 0.92
Isolated mesopic rod and cone electroretinograms realized with a four-primary method. Doc Ophthalmol (2011) 0.90
A novel IMPDH1 mutation (Arg231Pro) in a family with a severe form of autosomal dominant retinitis pigmentosa. Ophthalmology (2004) 0.90
Anisometropic amblyopia: spatial contrast sensitivity deficits in inferred magnocellular and parvocellular vision. Invest Ophthalmol Vis Sci (2007) 0.90
Atypical presentation of pattern dystrophy in two families with peripherin/RDS mutations. Ophthalmology (2002) 0.89
CRB1 heterozygotes with regional retinal dysfunction: implications for genetic testing of leber congenital amaurosis. Invest Ophthalmol Vis Sci (2006) 0.89
Characteristics of contrast processing deficits in X-linked retinoschisis. Vision Res (2005) 0.88
Dorzolamide use in the management of macular cysts in a patient with enhanced s-cone syndrome. Retin Cases Brief Rep (2009) 0.87
Activation phase of cone phototransduction and the flicker electroretinogram in retinitis pigmentosa. Vision Res (2006) 0.87
Spectral-domain optical coherence tomography and fundus autofluorescence characteristics in patients with fundus albipunctatus and retinitis punctata albescens. Ophthalmic Genet (2010) 0.87
Evaluation of retinal nerve fiber layer thickness in patients with retinitis pigmentosa using spectral-domain optical coherence tomography. Retina (2012) 0.87